Rare bone cancer study hunts for hidden genetic triggers
NCT ID NCT01200680
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find genetic changes that may cause sporadic chordoma, a rare bone cancer. Researchers will collect saliva and medical records from 188 patients across the U.S. and Canada who are the only ones in their family with chordoma. No treatment is given; the goal is to understand what genes might be involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify genetic risk factors for sporadic chordoma, pointing toward future targets for screening or treatment.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear genetic links, and results may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Westat, Inc.
Rockville, Maryland, 20850, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.